Cowen Group, Inc. Announces 2008 First Quart... (this ratio. We have reported in this ...)

Cowen Group, Inc. Announces 2008 First Quarter Results

Date:5/8/2008

this ratio.

We have reported in this press release our core brokerage revenue for the quarters ended March 31, 2008, March 31, 2007 and December 31, 2007 on a non-GAAP basis by:

-- excluding the income or loss from warrants, asset management seed

funds, restricted stock received in connection with the

demutualization of certain exchanges and mutual fund investments held

as a hedge against legacy deferred compensation obligations.

Management believes that the non-GAAP calculation of core brokerage revenue will allow for a better understanding of the revenue generated by our sales and trading activities as it excludes gains and losses associated with activities that are not conducted by our sales and trading professionals, but that are required to be reported in the brokerage line item.

SOURCE Cowen Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine news :

1. ISTA Pharmaceuticals Engages Cowen as Financial Advisor
2. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
3. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
4. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
5. MannKind to Present at the Cowen and Company Healthcare Conference
6. Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
7. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
8. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
9. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
10. Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17
11. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference

Post Your Comments:

(Date:11/25/2009)...ation and treatment clinics to resume Monday, Nov....ovember 25, 2009 -- Centegra Health System is cont...ne shots at four Centegra Primary Care (CPC) vacci...as arrived. The clinics are at CPC sites in Huntle... open as follows: , From 4:30 to 7:3...

(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...

(Date:11/25/2009)...re/-- MISSIONSkincare ®isproudtosupportGNC,se...NC,sannualSt.Jude ThanksandGiving campaign,$1fromt...ER-C(TM)LipBalm willbedonatedtoSt.Jude.Additionall...onationatcheckoutatoneoftheir5,000+retaillocations...Judeduringtheir2009 ThanksandGiving campaign. ,...

(Date:11/25/2009)...nforthe4thStraightYear ,, WASHINGTON,Nov.25/P...Georgia(LCA-GA)issuedthe 4thAnnualReportCardonLung...eagainstthislethaldiseaseinthestateofGeorgia.LCA-G...alorganizationdedicatedexclusivelytopatientsupport...r. ,, (Logo: http://www.newscom.com/cgi-bin/prn...

(Date:11/25/2009)...al cancer also can reverse a rare stomach disorder...he disease, researchers at Vanderbilt University M...se causes thickening of the stomach lining, severe...nemia and swelling in the feet and ankles due to p...stric cancer. Previously, the only effective treat...

Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4 Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2 Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2 Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2

[0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 [0] Long-Term Problems Linked to Testicular Cancer Chemo [2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)[0] Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer [1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder

...an research groups are undertaking pioneering stud...ing to patients receiving new drug treatments as e...fessor Shaun Jackson from The Australian Centre fo...tigating the impact of the bone marrow microenviro...

...arch 9, 2009 An easily implementable technique to...ed through angioplasty and stent insertion has bee...nsky of the Hebrew University of Jerusalem. , A... to part of the beating heart, usually due to plaq...

...n California Practice to Join SpectraScience Netwo...ystem , , SAN DIEGO, March 9 SpectraScience, Inc...dical device company, today announced that it has ... founder of Women,s Integrative Health, stated, "W...

...March 9 CEL-SCI Corporation (NYSE Alternext US: C...clusive licensing agreement with Byron Biopharma (...exclusive license to market and distribute the Com...th Teva Pharmaceuticals and Orient Europharma. , ...

... Journal of Radiation Oncology*Biology*Physics Stu...stem Provides Enhanced Image Information for Plann...REAL, March 4 Researchers report in the February ... enhanced image information to enable radiation on...

...., March 9 VirtualHealth Technologies, Inc. (OTC ...ve immediately it,s subsidiary Envoii Healthcare, ...o better reflect it,s focus on eHealth Security pr...t on growing our opportunities in this evolving cl...

Other Medicine News:Health News:World first treatment for leukemia being developed in Australia 2 Health News: Hebrew University scientist develop technique for eliminating reblockage of arteries 2 Health News:Women's Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System 2 Health News:Women's Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System 3 Health News:CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa 2 Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 2 Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 3 Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 4 Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 2 Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 3

World first treatment for leukemia being developed in Australia Hebrew University scientist develop technique for eliminating reblockage of arteries Women's Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region Envoii Healthcare, LLC is now Secure eHealth, LLC

(Date:11/25/2009)....,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.tod...iefexecutiveofficer,willpresentatthePiperJaffray21...1,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fer...gantibioticclinicalprogramsforthetreatmentofdrug-r...Pharmaceuticals ,, Foundedin2006,CempraPharmac...

(Date:11/25/2009)...alif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,anno...y,sPROTECT-1(theProspectiveRandomizedOralTherapyEv...X282-B)inpatientswithmoderate-to-severeCrohn,sdise...yandtolerabilityprofile.Thestudydemonstratedeviden...yasdefinedasa70-pointdecreaseintheCrohn,sDiseaseAc...

(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRM...nofReorganizationandDisclosureStatementtoday,Novem...eDistrictofDelaware.Ahearingtoconsiderapprovalofth...r8,2009,withthehearingontheconfirmationofthePlansc...ompanytopayallclaimsinfull.ThePlanisexpected,ifapp...

[0] Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference [0] ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference [0] Vermillion Files Plan of Reorganization

... increase in advanced non-small cell, lung cancer ...clitaxel and cisplat...include reductions in chemotherapy-indu...OKYO, March 18 BioNumerik,Pharmaceuticals, Inc. (...ASKA") today announced the results of a Phase III ...

... 2b in Second Quarter of 2008 - - Conferen... DIEGO, March 17 Ardea Biosciences, Inc.,(Nasdaq:...lts from its,ongoing Phase 2a proof-of-concept stu...oside reverse transcriptase inhibitor (NNRTI), in,... Preliminary results from the first two of three ...

Other Medicine Technology:BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 2 BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 3 BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 4 BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 5 Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2 Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3 Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4

BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load

UPJ Occlusion Balloon Catheter

Omega NV Balloon Ureteral Dilator Sets

AquaGuide Ureteral Access Sheath

Flexible Ureteroscopy Sheath Set

Medicine Products:

UPJ Occlusion Balloon Catheter Omega NV Balloon Ureteral Dilator Sets AquaGuide Ureteral Access Sheath Flexible Ureteroscopy Sheath Set

Cowen Group, Inc. Announces 2008 First Quart...(this ratio. We have reported in this ...),Health